Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes
about
Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint BlockadeA Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All CancersPredictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer.Cancer vaccines: Trafficking of tumor-specific T cells to tumor after therapeutic vaccination.Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge.Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure).Whole Cell Therapeutic Vaccine Modified With Hyper-IL6 for Combinational Treatment of Nonresected Advanced Melanoma.Emerging therapeutic targets in metastatic progression: A focus on breast cancer.Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer.The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.Hypoxia in the intestine or solid tumors: a beneficial or deleterious alarm signal?Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy.Synthetic biology in cell-based cancer immunotherapy.Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series.Preclinical rationale for combining radiation therapy and immunotherapy beyond checkpoint inhibitors (i.e., CART).Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors.Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.Vessel pruning or healing: endothelial metabolism as a novel target?Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors.Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma.T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics.Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment.A Multi-Compartment Hybrid Computational Model Predicts Key Roles for Dendritic Cells in Tuberculosis Infection.Trial Watch: Adoptively transferred cells for anticancer immunotherapy.A Task Force Against Local Inflammation and Cancer: Lymphocyte Trafficking to and Within the Skin
P2860
Q26769977-77C26DB5-0667-4074-9209-9204EBE81B0CQ26777111-596ABAAA-06FA-4127-83C1-46E0F0787C3BQ33584033-DB29C357-AB78-4717-95ED-8B1D938237B1Q33954123-5132AA19-8C57-43BE-B577-A036257368F4Q34859794-3CEF3D5B-C2B1-459F-85DC-488EAB109BE1Q36024656-31C1A375-6D03-4E7B-B2B3-411D09DDA6EAQ36193892-EB3AA207-8E52-4D9E-BE67-A508FB9023B5Q36854062-15FF5A73-C416-4FCB-BA3E-AA4EDBEFEB1FQ36936564-B85D28E9-A94D-4152-9162-8CE9483A19A3Q37516448-BB1B0EDE-A0E5-41FF-8AFF-C44E9C1CC890Q38231920-0242BBFB-A027-4EAD-8BEC-AE6543F16C2DQ38284345-653CB49A-0332-49BF-94BE-3ECBDA0FB6C2Q38531361-ADAD8F56-8970-4126-9FBD-06B64E47D6C1Q38621228-D337D312-62CD-422F-8D3E-18F941516B3CQ38681083-189360DC-B7B9-4D02-8B70-76B061CFCC31Q38769271-68398904-4264-4AD3-846B-4EB8F79C61B6Q38848404-6E38DD0C-3268-42BD-842C-CC3E1B23B3E6Q38873974-F50D98D9-CC55-4851-AE6D-526BB5279E10Q39024164-FB53C05D-8557-424D-9ADB-29AE342D28F7Q41483538-E8598CF5-694C-4359-B64D-2E31A6261E1AQ41789122-B7DC931F-B3E9-4182-AB83-3C5A550EECF1Q47570404-C5F1652E-517A-441C-82B3-607F4D7E1DF6Q51097491-D5755AB4-E517-4F21-B1C8-9C2C1C9A1026Q51574513-61B81BA9-CF4B-4D55-9181-BE059586FB5BQ52780137-1F98BC21-DDAB-4C79-8F92-83E3F7899017Q58566631-62472FA5-45D9-4868-A0CB-6157BF1E32FF
P2860
Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Ways to enhance lymphocyte tra ...... tumor infiltrating lymphocytes
@ast
Ways to enhance lymphocyte tra ...... tumor infiltrating lymphocytes
@en
Ways to enhance lymphocyte tra ...... tumor infiltrating lymphocytes
@nl
type
label
Ways to enhance lymphocyte tra ...... tumor infiltrating lymphocytes
@ast
Ways to enhance lymphocyte tra ...... tumor infiltrating lymphocytes
@en
Ways to enhance lymphocyte tra ...... tumor infiltrating lymphocytes
@nl
prefLabel
Ways to enhance lymphocyte tra ...... tumor infiltrating lymphocytes
@ast
Ways to enhance lymphocyte tra ...... tumor infiltrating lymphocytes
@en
Ways to enhance lymphocyte tra ...... tumor infiltrating lymphocytes
@nl
P2860
P3181
P356
P1476
Ways to enhance lymphocyte tra ...... tumor infiltrating lymphocytes
@en
P2093
Arianna Calcinotto
Matteo Bellone
P2860
P3181
P356
10.3389/FONC.2013.00231
P407
P577
2013-09-11T00:00:00Z